| Literature DB >> 29101630 |
Vykuntaraju K Gowda1, Varunvenkat M Srinivasan2, Maya Bhat3, Naveen Benakappa2.
Abstract
Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in SLC19A3 gene. It usually presents with encephalopathy and dystonia; if not treated, can progress to quadriparesis and death. Two Indian siblings born to a consanguineous marriage presented with regression of milestones, epilepsy and dystonia. Neuroimaging showed signal changes in basal ganglia and thalami. Genetic testing showed a homozygous missense substitution p.Gly23Val (c.68G > T) in exon 2 of the SLC19A3 gene. Thus to conclude, any child who presents with neuroregression, epilepsy and dystonia in the background of basal ganglia changes on neuroimaging, a possibility of biotin thiamine responsive basal ganglia disease should be considered.Entities:
Keywords: Biotin thiamine responsive basal ganglia disease; Dystonia; Neuroregression; SLC19A3 gene
Mesh:
Substances:
Year: 2017 PMID: 29101630 DOI: 10.1007/s12098-017-2471-5
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 1.967